Search
for

    Research 10 of 1000+

    1. Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review BMJ Open · 2019 · 17 citations
    2. TLRgeting Evasion of Immune Pathways in Glioblastoma Cell Stem Cell · 2017 · 15 citations
    3. BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases British Journal of Dermatology · 2025
    4. Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways Genes and immunity · 2017 · 14 citations
    5. Hair loss and its management in children Expert Review of Dermatology · 2011 · 5 citations
    6. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing 2020 · 34 citations
    7. Table 1_Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata.docx Figshare · 2025
    8. JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases Frontiers in Immunology · 2026
    9. 63418 JAK3/TEC kinase pathways are active in alopecia areata lesions, and their inhibition with Ritlecitinib prevents αCD3/αCD28+IL-2 induced immune privilege collapse in healthy hair follicles ex vivo Journal of the American Academy of Dermatology · 2025
    10. 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata 2019
    All research results →

    Learn 2 of 10

    1. Tofacitinib JAK inhibitor pill, an immune-system drug
    2. Rapamycin Immune-suppressing drug, also called sirolimus
    All learn results →

    Community

    — no results

    Try a deeper search in community →